Spanish Validation Frustration Discomfort Scale

Spanish Validation of the Frustration Discomfort Scale

This is an observational study aimed at validating the Frustration Discomfort Scale (Harrington, 2005). A back-translation process was followed to obtain a translated version of the scale, which was refined after a discussion with several clinicians.

Study Overview

• Status: Completed
• Conditions: General Population, no Specific Condition

Detailed Description

In the study, the Spanish adaptation of the Frustration Discomfort Scale will be disseminated with an online questionnaire using the Qualtrics platform. Additional questionnaires to explore the validity of the adapted scale will also be administered. Participants who complete the questionnaires and provide a valid ID number will enter a participate in a raffle to win an Amazon coupon of 40 euros. Ten coupons will be offered in total amongst participants.

• Study Type: Observational
• Enrollment (Actual): 1513

Contacts and Locations

Study Locations

• Spain
  • Castellón De La Plana, Spain
    • Faculty of Psycholoy. Jaume I University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

This protocol will be disseminated globally to the population in Spain with no restriction. The maximum efforts will be made to disseminate the study to a wide range of individuals

Description

Inclusion Criteria:

• Being over 18 years of age
• Signs the informed consent
• Can read and understand Spanish
• Has access to a computer, a tablet or a smartphone with an internet connection

Exclusion Criteria:

• Being younger than 18 years of age
• Does not sign the informed consent
• Cannot read or understand Spanish
• Does not have access to a computer, a tablet or a smartphone with an internet connection

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Frustration Discomfort Scale	This is a measure of frustration intolerance. The original English version has been translated using a back-translation method and discussions about item have been made with clinicians with expertise in the field. The scale has 28 items that are gouped in 4 subscales. Items have a 1-to-5 response scale ranging from "nothing" to "a lot"	The measure will be administered 1 day once only together with the remaining measures

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Rosenberg self-esteem scale	This scale of self-esteem has 10 items with responses ranging from 1 (completely agree) to 4 (completely disagree). This measure will be used for concurrent criterion validity analyses	The measure will be administered 1 day once only together with the remaining measures
Satisfaction with life scale	This 5-item scale measures an individual's satisfaction with life using response options ranging from 1 (completely disagree) to 5 (completely agree). This measure will be used for concurrent criterion validity analyses	The measure will be administered 1 day once only together with the remaining measures
Acceptance and action questionnaire - II	This 7-item scale measures acceptance of difficult experiences using a 7-point response scale (1= never true; 7=always true). This measure will be used for construct validity analyses	The measure will be administered 1 day once only together with the remaining measures
STAXI - 2 (trait anger scale only)	The trait anger scale of the STAXI-2, which has 10 items, will be used to evaluate trait anger. The responses in the scale range from 1="not at all" to 4="very much". This measure will be used for concurrent criterion validity analyses	The measure will be administered 1 day once only together with the remaining measures
Irrational Procrastination Scale	This 9-item scale will be administered to measure perceived procrastination. Items in the scale have a 5-point range (1=does not describe me at all; 5=decribes me completely). This measure will be used for concurrent criterion validity analyses	The measure will be administered 1 day once only together with the remaining measures
Trait Injustice Experiences Questionnare	This measure of perceived trait injustice beliefs has 12 items, with responses ranging from 0="never" to 4="always". This measure will be used for construct validity analyses	The measure will be administered 1 day once only together with the remaining measures
European version of the Perceived Stress Scale	This 10-item measure of perceived stress will be used for concurrent criterion validity analyses. Responses in the scale range from 0="never" to 4="very frequently"	The measure will be administered 1 day once only together with the remaining measures
Patient Health Questionnaire	This 10-item measure of depressive symptoms will be used for concurrent criterion validity analyses. Response scales range from 0="None of the days" to 3="Almost all days"	The measure will be administered 1 day once only together with the remaining measures
General Anxiety Disorder scale	This 7-item measure of anxiety symptoms will be used for concurrent criterion validity analyses. Response scales range from 0="None of the days" to 3="Almost all days"	The measure will be administered 1 day once only together with the remaining measures
General Attitudes and Beliefs Scale - reduced	A shortened, 12-item version of the General Attitudes and Beliefs Scale will be administered. This measure will be used for concurrent criterion validity analyses. Responses in the scale have a 1-5 range (1="completely disagree"; 5="completely agree")	The measure will be administered 1 day once only together with the remaining measures

Collaborators and Investigators

• Sponsor: Universitat Jaume I
• Collaborators: Universidad de Zaragoza; University of Seville; Universidad Rey Juan Carlos

Study record dates

Study Major Dates

• Study Start (Actual): January 10, 2020
• Primary Completion (Actual): May 30, 2020
• Study Completion (Actual): May 30, 2020

Study Registration Dates

• First Submitted: January 20, 2020
• First Submitted That Met QC Criteria: January 22, 2020
• First Posted (Actual): January 23, 2020

Study Record Updates

• Last Update Posted (Actual): June 18, 2020
• Last Update Submitted That Met QC Criteria: June 17, 2020
• Last Verified: May 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: FrustrationUJI

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Only the main PI will have access to the data.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No